Enovix (NASDAQ:ENVX – Get Free Report) updated its first quarter 2025 earnings guidance on Wednesday. The company provided EPS guidance of -0.210–0.150 for the period, compared to the consensus EPS estimate of -0.170. The company issued revenue guidance of $3.5 million-$5.5 million, compared to the consensus revenue estimate of $6.2 million.
Enovix Stock Down 7.1 %
Shares of ENVX stock traded down $0.80 on Thursday, reaching $10.39. 5,361,402 shares of the company were exchanged, compared to its average volume of 6,888,279. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. The company has a 50-day moving average of $11.06 and a 200-day moving average of $10.29. The company has a market cap of $1.85 billion, a price-to-earnings ratio of -6.50 and a beta of 1.87. Enovix has a one year low of $5.70 and a one year high of $18.68.
Enovix (NASDAQ:ENVX – Get Free Report) last issued its earnings results on Wednesday, February 19th. The company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.01. The company had revenue of $9.72 million for the quarter, compared to analyst estimates of $8.77 million. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. Analysts anticipate that Enovix will post -1.16 earnings per share for the current year.
Analysts Set New Price Targets
Get Our Latest Research Report on Enovix
Insider Buying and Selling at Enovix
In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the completion of the transaction, the director now directly owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. This represents a 42.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 15.70% of the company’s stock.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Stories
- Five stocks we like better than Enovix
- Ride Out The Recession With These Dividend Kings
- Tesla: 2 Reasons to Buy, 1 Reason to Run
- 3 Monster Growth Stocks to Buy Now
- Should You Hold NVIDIA Stock for the Long Haul or Trade It?
- What Are Treasury Bonds?
- Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.